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Background: Mammalian target of rapamycin (mTOR) is an evolutionarily conserved serine/threonine kinase that is
a central regulator of cell growth and metabolism. CCI-779 is a specific inhibitor of the mTORC1 signaling pathway.
Results: We performed comparative transcriptome profiling on Inner Mongolia Cashmere goat fetal fibroblasts
(GFbs) that were treated with CCI-779 and untreated cells. A total of 365 differentially expressed genes (DEGs)
appeared between untreated and CCI-779-treated GFbs, with an FDR ≤0.001 and fold-change ≥2. These 365 DEGs
were associated with mTOR signaling; 144 were upregulated in CCI-779-treated cells, and 221 were downregulated.
Additionally, 300 genes were annotated with 43 Gene Ontology (GO) terms, and 293 genes were annotated with
194 Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways. Three RNA polymerase II and polymerase III
subunits, 3 transcription factors, and 5 kinases in mTOR signaling were differentially expressed in CCI-779-treated
GFbs. Further 6 DEGs were related to amino acid metabolism, 11 mediated lipid metabolism, 11 participated in
carbohydrate metabolism, and 5 were involved in single-nucleotide metabolism. Based on our quantitative
transcriptomic analysis, 40 significant DEGs with important function related to metabolism, RNA polymerase,
transcription factors and mTOR signaling were selected for qPCR analysis, and the quantitative results between the
two analysis methods were concordant. The qPCR data confirmed the differential expression in the RNA-Seq
experiments. To validate the translational significance of the findings in certain differentially expressed genes, S6K1
and VEGF were detected by western blot, and these two proteins showed a differential expression between non-
treated and treated with CCI-779 groups, which were consistent with mRNA abundance. The data showed a
preliminary significance of the findings in the protein levels.
Conclusions: CCI-779 induces transcriptomic changes, and mTOR signaling might have significant function in the
activation of RNA polymerase and certain transcription factors and in the metabolism of amino acids, lipids,
carbohydrates, and single nucleotides in GFbs. These data filled the vacancy in the systematical profiling of mTOR
signaling on Cashmere goat fetal fibroblasts.
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Mammalian target of rapamycin (mTOR) is an evolu-
tionarily conserved serine/threonine kinase that belongs
to the phosphatidylinositol kinase-related kinase (PIKK)
family. mTOR was renamed mechanistic target of rapa-
mycin (MTOR) by the Human Genome Organization
(HUGO) Gene Nomenclature Committee (HGNC).
mTOR exists as 2 physically and functionally distinct
protein complexes, mTORC1 and mTORC2; is a central
regulator of cell growth and metabolism; and is sufficient
to induce specific metabolic processes [1]. Pharmaco-
logical and genetic studies have demonstrated that
mTORC1 activation influences cell growth and metabol-
ism in various organisms, from yeast to human [2].
mTORC1 inhibition decreases protein synthesis and
gene transcription. The mTOR signaling pathway is
emerging as a significant regulator of gene transcription,
governing various cellular processes [3]. It is likely that
the physiological significance of mTOR signaling will ex-
pand. mTORC1 has a distinct function in cell metabol-
ism, depending on the environmental nutrient status [4].
With sufficient nutrients, mTORC1 positively regulates
anabolic processes, including protein synthesis, lipid syn-
thesis, ribosome biogenesis, and nucleotide biosynthesis
[5]. De novo nucleotide biosynthesis is an approach for
providing building blocks for DNA and RNA. Increasing
evidence from functional genomics studies suggests that
mTORC1 signaling promotes nucleotide biosynthesis
[6]. Recent studies have demonstrated that mTORC1
signaling post-translationally regulates de novo pyrimi-
dine synthesis through its downstream target ribosomal
protein S6 kinase 1 (S6K1), which phosphorylates S1859
of CAD (carbamoyl-phosphate synthetase 2, aspartate
transcarbamoylase, dihydroorotase), the enzyme that cat-
alyzes the 3 three steps of de novo pyrimidine synthesis
[7, 8]. New pyrimidine synthesis can accommodate in-
creased DNA and RNA synthesis.
Lipid biosynthesis is essential for maintaining cellular
homeostasis. mTOR signaling has a fundamental func-
tion in regulating various aspects of lipid metabolism in
mammalian cells, including lipogenesis, adipogenesis,
lipolysis, and lipid oxidation [9, 10]. mTORC1 promotes
de novo lipogenesis through the activation of SREBP-1
(sterol regulatory element-binding protein) and PPAR-γ
(peroxisome proliferator-activated receptor) [11, 12].
Moreover, inhibition of mTOR signaling promotes lip-
olysis, thermogenesis, and lipid storage [13–15]. mTOR
signaling is important in the maintenance of systemic
lipid homeostasis.
It is believed that mTORC1 has a significant function
in energy homeostasis in a cell-autonomous [16]. In
many cell systems, mTORC1 couples PI3K (phosphoino-
sitide 3-kinase) and PKB (protein kinase B) to control
glucose uptake [17, 18] and glycosis [19, 20]. mTORC1is linked to the control of glycolysis through 2 transcrip-
tion factors, c-Myc and HIF (hypoxia-inducible factor)
1α, each of which upregulates glycolytic enzymes and
glucose transporters [21]. Further, mitochondria are the
main site of ATP production, and mTOR signaling is as-
sociated with the activation of mitochondria and ATP
synthase [22, 23].
mTORC1 activity depends strictly on sufficient levels
of intracellular amino acids, because amino acids are es-
sential for mTORC1 activity [24], leucine is believed to
promote energy metabolism, including glucose uptake,
mitochondrial biosynthesis, and fatty acid oxidation, to
provide energy for protein synthesis while inhibiting
protein degradation [25]; yet, the function of mTOR in
amino acid catabolism remains unknown.
mTORC1 governs transcription, as first characterized
in yeast, and mTORC1 inhibition also affects the expres-
sion of important genes in mammalian cells [26].
mTORC1 alters gene expression by impacting the activ-
ity of transcription factors, including STAT3, TFEB,
NRF1, HIF1α, and YY1-PGC1α [27]. Further, mTOR sig-
naling governs the synthesis of Pol I-transcribed 45S
rDNA and Pol III-transcribed genes, including tRNA
and 5S rRNA, by binding to the promoters of RNA poly-
merase I- and III-transcribed genes [28]. mTOR associ-
ates with TFIIIC, a DNA-binding factor that resides in
tRNA and 5S rRNA genes, and targets their repressor,
Maf1 [29]. The mTOR kinase is required for the regula-
tion of Maf1 phosphorylation and the control of RNA
polymerase III-dependent transcription [30]. mTOR
might be involved in the activities of all 3 RNA
polymerases.
RNA-Seq generates deep sequencing data for the
direct quantification of transcripts. Integrative tran-
scriptome analysis was performed to decipher the mo-
lecular mechanism underlying rapamycin-induced
anti-tumor and anti-angiogenic effects, and a tran-
scriptional network was discovered to be enriched for
genes that were related to angiogenesis and extracel-
lular matrix remodeling [31]. RNA-Seq revealed the
activation of an aurora kinase-driven mTOR pathway
in patients with sarcomatoid metastatic renal cell car-
cinoma [32]. These studies are helpful in examining
the regulation of cancer behavior that is mediated by
mTOR signaling. By high-throughput RNA-Seq, many
genes that were related to apoptosis and migration,
which enhance CTL survival into memory, were iden-
tified in mouse CTLs in which mTOR was inhibited
[33]. Profiling of the fetal and adult rat liver tran-
scriptome confirmed that mTOR signaling in liver has
distinct physiological functions in the adult and fetus
[34]. Using RNA-Seq to find regulatory networks and
novel regulators can help us to decipher mTOR
signaling.
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examined in human, mouse, and rat but not in cashmere
goat, due to the lack of basic data in this animal. To
study the physiological significance of mTORC1 signal-
ing in Inner Mongolia Cashmere goat cells, we used
RNA-Seq to examine genome-wide gene expression dif-
ferences in cashmere goat fetal fibroblasts in which
mTORC1 activation was inhibited. In our previous stud-
ies, treatment of goat fetal fibroblasts with CCI-779
inhibited mTOR signaling and proliferation in vitro [35].
CCI-779, also called temsirolimus or rapamycin 42-[2,2-
bis (hydroxymethyl) propionate], is an ester of rapamy-
cin and a specific inhibitor of mTORC1. In the current
study, we used CCI-779 to treat cashmere goat fetal fi-
broblasts and to examine genome-wide gene expression
differences. Differentially expressed genes (DEGs)
compared to untreated cells were identified from a
whole-transcriptome background. Our data suggest that
the expression of RNA polymerase subunits; certain tran-
scription factors; and important enzymes in amino acid,
lipid, carbohydrate, and single nucleotide metabolism is
regulated by mTORC1 in goat fetal fibroblasts.Fig. 1 Overall design of experiment. Inner Mongolia Cashmere goat fetal fi
modified Eagle’s medium (DMEM)/F12, supplemented with 10 % fetal bovi
were treated with 50 nM CCI-779 (temsirolimus) for 12 h were cultured in
each sample. The cells processing were repeated 3 times and to isolate tot
for RNA-seqMethods
Cell culture conditions and design of experiment
Inner Mongolia Cashmere goat fetal fibroblasts (GFbs)
were maintained as monolayer cultures in Dulbecco
modified Eagle’s medium (DMEM)/F12 (Gibco, Paisley,
PA49RF, Scotland, UK), supplemented with 10 % fetal
bovine serum (FBS, Hyclone Laboratories, Inc. Logan,
UT, USA) and penicillin/streptomycin (Sigma-Aldrich,
Inc. St. Louis, USA). Cell cultures were maintained and
incubated at 37 °C in humidified air with 5 % CO2. The
P2 ~ P4 cells were used for all experiments. Untreated
GFbs and GFbs treated with 50 nM CCI-779 (temsiroli-
mus) for 12 h were cultured in petri dishes (diameter =
100 mm), respectively, and 5.8 × 106 cells were collected
for each sample. The cells processing were repeated 3
times and to isolate total RNA, separately. Then, the 3
isolated total RNAs were mixed for RNA-seq (Fig. 1).
CCI-779, a derivative of rapamycin, was synthesized by
Selleck Chemicals LLC (Huston, Texas, USA) and dis-
solved in DMSO (Sigma Chemical Corp., St. Louis,
MO). The concentration of DMSO in the final solution
was 0.5 % (v/v).broblasts (GFbs) were maintained as monolayer cultures in Dulbecco
ne serum and penicillin/streptomycin. Untreated GFbs and GFbs that
petri dishes (diameter = 100 mm), and 5.8 × 106 cells were collected for
al RNA separately. Then, the 3 isolated total RNAs were mixed
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Total RNA from control and CCI-779-treated GFbs was
extracted using RNAzol (RNAiso Plus, TaKaRa Co. Lts.,
China) per the manufacturer’s instructions. RNA sam-
ples were then digested with RNase-free DNase I to
eliminate residual genomic DNA, and the digestion
products were purified using magnetic beads. The total
RNA that had a standard of concentration ≥ 200 ng/μl,
mass ≥ 10 μg, 28 S/18 S ≥ 1.0, and RNA integrity number
(RIN) ≥ 7.0, as measured on an Agilent 2100 Bioanalyzer
(Agilent technologies Inc., Santa Clara, CA, USA), was
subjected to RNA-Seq.
cDNA library construction and sequencing
mRNA for each sample was enriched using oligo (dT)
magnetic beads, mixed with fragmentation buffer, and
fragmented (approximately 200 bp). Then, first-strand
cDNA was synthesized using random hexamer-primed
reverse transcription, and second-strand cDNA was syn-
thesized. The integrity and size were checked on an
Agilent 2100 Bioanalyzer (Agilent technologies Inc.,
Santa Clara, CA, USA), and the cDNA library was se-
quenced on an Ion Proton platform (Life Technologies,
Carlsbad, CA, USA).
Sequence data processing and alignment with reference
The sequencing-obtained raw image data were transformed
into sequence data, called raw data or raw reads, which
were deposited in the SRA (http://www.ncbi.nlm.nih.gov/
sra/) database under the submission number of SRP085885.
Clean reads were obtained by trimming the adaptor se-
quences and removing ambiguous nucleotides, low-quality
sequences, contaminated microbial sequences, and riboso-
mal RNA sequences. SOAP2 [36] was used to align all
clean reads to the reference gene (http://ftp.ncbi.
nih.gov/genomes/Capra_hircus/RNA/) and reference
genome (http://ftp.ncbi.nih.gov/genomes/Capra_hir
cus/Assembled_chromosomes/seq/). Then, the length
distribution, alignment statistics, sequencing satur-
ation, randomness assessment, and distribution of
reads against the reference gene and genome were
analyzed.
Screening and functional analysis of differentially
expressed genes
The expression level of each gene was determined by the
number of reads that was uniquely mapped to a specific
gene and the total number of uniquely mapped reads in
the samples. Expression level was calculated using the
RPKM algorithm (reads per kb per million reads) [37].
The RPKM method eliminates the influence of gene
length and sequencing discrepancies in calculating ex-
pression. Thus, RPKM values can be used directly to
compare differences in expression between samples.Differentially expressed genes (DEGs) were
screened, based on Poisson distribution analysis [38],
a strict algorithm that identifies DEGs between 2
samples. Genes were considered to be differentially
expressed if they met the following criteria: fold-
change ≥ 2 and FDR ≤ 0.001. The functional character-
istics of DEGs were analyzed by pairwise comparison.
Using BLAST (2.2.23) and Blast2GO (2.2.5) [39], the
DEGs were provided with functional annotations, in-
cluding Gene Ontology (GO) and Kyoto Encyclopedia
of Genes and Genomes (KEGG). Cluster (3.0) [40]
and Java TreeView (1.1.6r2) were used to perform
cluster analysis of gene expression patterns. GO terms
that met a corrected p-value ≤ 0.05 were defined as
significantly enriched GO terms. The nr database,
compiled by the NCBI (http://www.ncbi.nlm.nih.gov/)
as a comprehensive protein database for BLAST
searches, was used Blast2GO to obtain the GO anno-
tation of DEGs. WEGO [41] was used to perform a
functional classification of the DEGs and understand
the distribution of gene functions on a macro level.
Pathway enrichment analysis was conducted with the
KEGG database [42].
Quantitative real-time PCR
A total of 40 genes were selected for quantitative real-time
PCR analysis, with the housekeeping gene β-actin as a ref-
erence. β-actin was amplified with the following primer
pair: forward 5′-CCACTGGCATTGTCATGGACTC-3′
and reverse 5′- TTCCTTGATGTCACGGACGATTT-3′.
Primers for all genes are listed in Additional file 1. Total
RNA from two groups’ composites (one RNA composite
from untreated cells and one from treated cells) was
reverse-transcribed with an oligo (dT)12–18 primer using
the AMV 1st Strand cDNA Synthesis Kit (Takara Co. Ltd.,
China). qPCR was performed on a Bio-Rad Chromo 4
PCR System using SYBR® Premix Ex Taq™ (Perfect Real
Time) (TaKaRa Co. Ltd., China); 1 μL cDNA was ampli-
fied in a 25-μl reaction, containing 10 mol/L forward pri-
mer (0.5 μl), 10 mol/L reverse primer (0.5 μl), 2 × SYBR®
Premix Ex Taq™ (12.5 μl), and nuclease-free water
(10.5 μl) with the following program: 95 °C for 5 min;
40 cycles of 95 °C for 15 s, 54 °C for 30 s, and 72 °C for
30 s; and 72 °C for 10 min. To get reliable calculation of
statistical significance, 3 samples per group and 3 tech-
nical replicas for per samples were performed for per dif-
ferentially expressed gene. 2-ΔΔCT values were calculated
to determine expression levels. The qPCR results were an-
alyzed by Student’s T test to compare expression between
2 groups.
Western blot analysis
GFb cells were plated onto 55 cm2 petri dishes at 3 × 105
per dish and incubated. Subconfluent cells (about 5.5 ×
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for 12 h, collected with trypsin, washed 3 times with
cold PBS, and lysed in buffer that contained 20 mM Tris
(pH 8.0), 137 mM NaCl, 100 g/L glycerol, 50 g/L Triton
X-100, 2 g/L Na2VO4, and 4 g/L EDTA; 10 ml PMSF
(0.1 M) and 10 ml ALT (10 g/L) were added per 1 ml
lysis buffer immediately before use. The cell lysates were
put on ice for 15 min and centrifuged at 15,000 rpm at
4 °C for 20 min, and the supernatant was transferred to
new tubes.
The concentrations of the lysates were measured by
Coomassie Plus (Bradford) Assay (Thermo Scientific).
Equal amounts (40 μg) of protein were electrophoresed
on 12 % (w/v) sodium dodecylsulfate polyacrylamide
gels. Proteins were transferred to Hybond-polyvinylidene
difluoride membranes (Amersham) and incubated with
the primary antibodies overnight at 4 °C and peroxidase-
conjugated secondary antibodies at room temperature
for 1 h. Enhanced chemiluminescence (ECL) (Amer-
sham) was used to detect the signals.Statistical analysis
Descriptive statistics were generated for all quantita-
tive data, expressed as mean ± SD. The mean ± SD
values were calculated from 3 samples per group and
3 technical replicas for per samples. Differences in
means between control and CCI-779-treated groups
were determined by Student’s T test. All statistical
analysis were performed using GraphPad Prism, v.5.00
(GraphPad Software, CA, USA).Results
RNA-Seq data processing, alignment, and assessment
RNA was isolated from control cells (Non-treated) and
50 nM CCI-779-treated cells for RNA sequencing ana-
lysis. By sequencing, 15,138,753 and 18,411,100 rawFig. 2 RNA sequencing data of comparison transcriptomic in untreated vs
within the control and CCI-779-treated groups. The red dots represent upre
downregulated genes; the blue dots show genes not differentially expresse
genes with functional correlations. c The number of DEGs in comparison trreads were generated for the control and CCI-779-
treated groups, respectively. After the removal of
adaptor sequences, ambiguous nucleotides, low-quality
sequences, contaminated microbial sequences, and ribo-
somal RNA sequences, a total of 14,689,607 and
17,861,831 clean reads with lengths of 120–150 bp from
2 sequencing libraries were gathered for further analysis.
Clean reads of 2 samples were aligned with TMAP {ver-
sion 3.4.1} to the goat reference genes and genome, and
uniquely aligning reads were summated to generate read
count-based gene expression estimates. The mapping ra-
tio to the reference genes ranged from 86.30 to 86.98 %,
and above 80 %, whereas the mapping ratio to the refer-
ence genome ranged from 98.14 to 98.35 %, exceeding
97 %.
Analysis of differentially expressed genes related to
mTOR signaling
To analyze DEGs that were related to mTORC1, all se-
quenced genes were screened between control cells and
treated cells (untreated vs CCI-779). A total of 365
DEGs that were related to mTORC1 were identified in
the transcriptomic comparison (Fig. 2a; Additional file 2),
comprising 144 upregulated and 221 downregulated DEGs
(Fig. 2b, c), suggesting that their expression was associated
with mTORC1 in GFb cells.
Functional analysis of differentially expressed genes in
untreated vs CCI-779-treated cells
To determine the functions of our DEGs, WEGO was
used to attach functional annotations to them. The
complete GO enrichment analysis of DEGs is included
in Additional file 3. GO functional classification of DEGs
was generalized as biological process, cellular process,
and molecular function (Fig. 3, Additional file 4), and
300 genes were annotated with 43 GO terms. Overall,
“cell (GO: 0005623) (231 genes),” “cell part (GO:CCI-779-treated cells. a The spots on the MA plot represent each gene
gulated genes in CCI-779-treated cells, and the green dots represent
d between groups. b Clustering of gene expression patterns reveals
anscriptomic in untreated vs CCI-779-treated cells
Fig. 3 GO functional classification statistics of proteins corresponding to genes in untreated vs CCI-779-treated cells. The y-axis represents number
and percent of genes, and the x-axis displays three categories by Gene Ontology: biological process, cellular component, and molecular function
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(177 genes)” were listed as the top Cellular Components;
“binding (GO: 0005488) (206 genes)” and “catalytic ac-
tivity (GO: 0003824) (95 genes)” were the top Molecular
Functions; and the most frequent Biological Processes
were “cellular process (GO: 0009987) (215 genes),” “sig-
nal-organism process (GO: 0044699) (166 genes),” and
“metabolic process (GO: 0008152) (173 genes).” Further,
DEGs were enriched in KEGG terms, and 293 genes
were annotated in 194 pathways, primarily “Metabolic
pathways,” “Focal adhesion,” and “Regulation of actin
cytoskeleton” (Additional file 5).
CCI-779 induces expression changes in genes encoding
proteins involved in mTOR signaling
To examine whether the proteins involved in mTORC1
signaling were differentially expressed in treated cells,
the encoding genes were identified by KEGG analysis.
Five genes were identified as being significantly altered
in untreated versus CCI-779-treated cells—phosphatidy-
linositol-3-kinase (PI3K) and vascular endothelial growth
factor VEGF (LOC102177848) were upregulated, and
ribosomal protein S6 kinase (S6K1), regulated in DNA
damage and development 1 (REDD1), and mouse pro-
tein 25 (MO25) were downregulated (Fig. 4), suggesting
that inhibition of mTORC1 changes the expression of
molecules that participate in this pathway.
CCI-779 induces expression changes in eukaryotic RNA
polymerase subunits and transcription factors in GFb cells
To determine whether the expression of DNA-directed
RNA polymerases or transcription factors were affected
by mTORC1 inhibition, the expression of several
eukaryotic RNA polymerase subunits and transcription
factors were analyzed in control and CCI-779-treatedGFbs. Eukaryotic RNA polymerase II subunit RPB1
(ODF3L2, B1) and polymerase III subunit POLR3G
(C31) were downregulated, whereas CMYA5 (C37) was
upregulated in CCI-779-treated GFb cells (Fig. 5). Three
transcription factors were differentially expressed—TCF20
was upregulated, and NRL and NFYB were downregu-
lated, indicating that their expression is regulated by
mTOR signaling.
Analysis of DEGs in amino acid metabolism related to
mTORC1
To determine the function of mTORC1 in amino acid
metabolism, a comparative analysis was performed in
untreated and CCI-779-treated cells. A total of 6 genes
were identified. Compared with control cells, in CCI-
779-treated GFbs, 2-oxoglutarate dehydrogenase E1
component (OGDH), short/branched chain acyl-CoA
dehydrogenase (ACADSB), and 2,3-bisphosphoglycerate-
dependent phosphoglycerate mutase (PGAM2) were up-
regulated in lysine, valine, leucine, isoleucine, glycine, serine,
and threonine metabolism. Glutathione S-transferase GST
(LOC102179473, LOC102189581, LOC102188913), 3-
hydroxyisobutyrate dehydrogenase mmsB (PSIP1), and
histamine N-methyltransferase (HNMT) were down-
regulated in glutathione, valine, leucine, isoleucine, and
histidine metabolism (Fig. 6). These data indicate that
mTORC1 has a significant function in amino acid
metabolism.
Analysis of DEGs in lipid metabolism related to mTORC1
To examine the regulatory mechanism of mTORC1 in
lipid metabolism and identify important molecules that
were related to mTORC1, we compared the expression
levels of genes that were associated with lipid metabolism
between CCI-779-treated and control cells. A total of 11
Fig. 4 CCI-779 treatment induces expression change in mTOR signaling pathway components. Heat map data transposed onto the KEGG mTOR
signaling pathway. REDD1, MO25, and S6K1/2 were downregulated (green box) and PI3K and VEGF (LOC102177848) were upregulated (red box) in
CCI-779-treated GFbs (FDR ≦0.001 and fold-change ≧2)
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pathways. 3-butanediol dehydrogenase bdh (BDH2),
sphingosine kinase SPHK (SPHK1), cytochrome P-450
(CYP) 1B1 (LOC102184252), phosphatidylinositol-4,5-
diphosphate-3-kinase PIK3C (PIK3CD), and prostaglandin-
endoperoxide synthase1 (PTGS1) were upregulated, while
whereas lysosomal acid lipase LIPA (LIPA), micro-
somal triglyceride transfer protein large subunit
(MTTP), triacylglycerol lipase ATGL (LIPG), juvenile
hormone acid methyltransferase (JHAMT), protein
farnesyltransferase subunit beta FNTB (CHURC1), and
decaprenyl-diphosphate synthase subunit1 (PDSS1) were
downregulated in treated cells (Fig. 7). BDH2, SPHK1,
CYP 1B1, PIK3CD, and PTGS1 mediate butanoate metab-
olism, sphingolipid metabolism, steroid hormone biosyn-
thesis, inositol phosphate metabolism and arachidonic acid
metabolism, respectively. LIPA, MTTP, LIPG, JHAMT,
CHURC1, and PDSS1 are involved in steroid biosynthesis,
fat digestion and absorption, glycerolipid metabolism, in-
sect hormone biosynthesis, and terpenoid backbone bio-
synthesis, respectively. These data suggest that mTOR
signaling regulates various aspects of lipid metabolism.
Analysis of DEGs in carbohydrate metabolism related to
mTORC1
To analyze DEGs in energy homeostasis that were related
to mTOR signaling, we focused on DEGs that mediated
carbohydrate metabolism in untreated versus CCI-779-
treated cells. Six genes were upregulated: chondroitin 6-
sulfotransferase3 (CHST3), 2-oxoglutarate dehydrogenase
E1 component (OGDH), phosphatidylinositol glycan(PIGK), 2,3-bisphosphoglycerate-dependent phosphoglyc-
erate mutase (PGAM2), ketohexokinase (KHK), and
cytochrome-b5 reductase Cyt b5R (LOC102173645).
The 5 genes that were downregulated in CCI-779-
treated GFbs were N4- (β- N-acetylglucosaminyl)-L-
asparaginase (AGA), oligosaccharide translocation protein
(RFT1), protein O-GlcNAc transferase OGT (TTC5), acyl-
phosphatase (ACYP1), and acetyl-CoA hydrolase ACH1
(STARD10) (Fig. 8). CHST3, OGDH, PIGK, PGAM2,
KHK, and Cyt b5R are involved in glycosaminoglycan bio-
synthesis, chondroitin sulfate biosynthesis, citrate cycle,
glycosylphosphatidylinositol (GPI)-anchor biosynthesis,
fructose and mannose metabolism, gluconeogenesis me-
tabolism, and amino sugar and nucleotide sugar metabol-
ism, respectively. AGA, RFT1, TTC5, ACYP1 and
STARD10 participate in glycan degradation, N-glycan bio-
synthesis, other types of O-glycan biosynthesis, and pyru-
vate metabolism, respectively. These results indicate that
carbohydrate metabolism is controlled by mTOR signaling
in GFbs.
Analysis of DEGs in single nucleotide metabolism related
to mTORC1
To determine the function of mTORC1 in single nu-
cleotide metabolism and identify important molecules
that are related to mTORC1, a comparative analysis
was performed in untreated versus CCI-779 cells. In
CCI-779-treated GFbs, uridine kinase udk (UCK1)
and guanylate cyclase 2 F (GUCY2F) were upregu-
lated in uridine/ cytidine and guanosine triphosphate
(GTP) metabolism, respectively, whereas, guanylate
Fig. 5 CCI-779 treatment induces expression changes in RNA polymerases subunit genes. Heat map data transposed onto the KEGG mTOR
signaling pathway. The eukaryotic Pol II core subunit RPB1 (ODF3L2, B1) and Pol III specific subunit POLR3G (C31) were downregulated (green
box), and eukaryotic Pol III specific subunit CMYA5 (C37) was upregulated (red box) in CCI-779-treated GFbs (FDR ≦0.001 and fold-change ≧2). The
black box indicates no significant change in expression
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nucleotide phosphodiesterase PDE8A and nucleoside-
diphosphate kinase ndk (LOC102176263) were down-
regulated in guanylate cyclization, 3′,5′-cyclic guanosine
monophosphate (3′,5′-cGMP) and deoxy-ribonucleoside
triphosphate (dNTP) metabolism, respectively (Fig. 9).
These results indicate that mTOR signaling is associated
with single nucleotide metabolism.
Confirmation of gene expression
To analyze the expression patterns of DEGs in the RNA-
Seq, 40 DEGs with important functions, including 32
DEGs in amino acid, lipid, carbohydrate, and single nu-
cleotide metabolism, 2 DEGs (VEGF and S6K1/2) in-
volved in mTOR signaling, 3 DEGs (RPB1, POLR3G and
CMYA5) related to RNA polymerase and 3 DEGs
(TCF20, NRL and NFYB) related to transcriptionfactors, were selected for quantitative real-time PCR
analysis, with β-actin as the reference gene. The qPCR
results showed high concordance with the RNA-Seq
data, suggesting that our RNA-Seq findings are reliable
(Fig. 10). The data are listed in Additional file 6. In
addition, statistical analysis was performed for 40 DEGs,
indicating that all quantitative data we achieved are reli-
able and the differential expression of each DEG be-
tween control and CCI-779-treated groups are all
significantly different (p < 0.05) (Fig. 11). Moreover,
genes that encoded enzymes in amino acid, lipid, carbo-
hydrate, and single nucleotide metabolism were differen-
tially expressed in mTORC1-inhibited GFbs. The
number of DEGs in lipid and carbohydrate metabolism
is more than that in amino acid and nucleotide metabol-
ism. In addition, the number of up-regulated DEGs equals
to down-regulated genes in amino acids metabolism; the
Fig. 6 CCI-779 treatment induces expression change in amino acid metabolism enzyme genes. GST (LOC102179473, LOC102189581,
LOC102188913), mmsB (PSIP1), and HNMT were downregulated (green box) and OGDH, ACADSB, and PGAM2 were upregulated (red box) in CCI-
779-treated GFbs (FDR ≦0.001 and fold-change ≧2). The black box indicates no significant change in expression
Fu et al. BMC Genomics  (2016) 17:879 Page 9 of 16number of down-regulated DEGs are more than up-regu-
lated genes in lipids and single nucleotides metabolism;
in contrast, the number of down-regulated DEGs are less
than up-regulated DEGs in carbohydrates metabolism
(Fig. 12). Thus, mTORC1 signaling might have disparate
functions in the metabolism of various macro-molecules.
Emerging evidence indicates that gene transcription
and steady-state levels of mRNA expression do not al-
ways predict protein levels [43]. To validate the protein
expression of certain differentially expressed genes as we
found in this study, S6K1 and VEGF were selected for
the detection by western blot analysis. These two pro-
teins showed a differential expression between non-
treated and treated with CCI-779 groups (p < 0.05). The
expression of S6K1 and VEGF were consistent with the
results of the transcriptional levels (Fig. 13, Additional
file 7: Figure S1). The data showed a preliminary signifi-
cance of the findings in the protein levels.
Discussion
The physiological and pathophysiological role of the
mTOR pathway have been well-characterized in variousorganisms, from yeast to human [2, 3] but not in Cash-
mere goat. In this study, the underlying biological effect of
inhibition of mTORC1 by specific chemical inhibitor CCI-
779 on Inner Mongolia Cashmere goat fibroblasts was
investigated, and the systematical profiling of mTOR sig-
naling on GFbs was analyzed. mTORC1 is a central regula-
tor of cell growth and metabolism, and is sufficient to
induce specific metabolic processes [1]. mTOR signaling is
emerging as a significant regulator of gene transcription,
governing various cellular processes [3]. In order to investi-
gate the regulation of mTOR signaling on key enzymes re-
lated to various metabolisms in GFbs, we present RNA-seq
analysis results on cells treated with CCI-779 and un-
treated cells; 365 DEGs were screened out in a transcrip-
tomic comparison of untreated versus CCI-779-treated
cells. Our analysis of DEGs that are associated with mTOR
signaling in eukaryotic RNA polymerase subunits, tran-
scription factors, and macromolecule metabolism provides
novel findings in GFb cells and thus constitute a valuable
genetic resource on the mechanisms of mTOR signaling in
regulating gene expression in the metabolism of cellular
amino acids, lipids, carbohydrates, and single nucleotides.
Fig. 7 CCI-779 treatment induces expression change in lipid metabolism enzyme genes. bdh (BDH2), SPHK1, CYP 1B1 (LOC102184252), PIK3C
(PIK3CD), and PTGS1 were downregulated (green box) and OGDH, ACADSB, and PGAM2 were upregulated (red box) in CCI-779-treated GFbs (FDR
≦0.001 and fold-change ≧2). The black box indicates no significant change in expression
Fu et al. BMC Genomics  (2016) 17:879 Page 10 of 16Inner Mongolia Cashmere goat is an economically im-
portant domestic animal with the best cashmere—cash-
mere goats have long been an excellent local variety of
cashmere and meat through natural evolution and artifi-
cial breeding. In this study, RNA-seq analysis was per-
formed to determine the effects of CCI-779 on GFbs.
CCI-779 is a specific inhibitor of mTORC1, and cells
treated with CCI-779 clearly experienced significant alter-
ations in mTORC1 signaling. In total, 144 genes were
upregulated and 221 genes were downregulated, in associ-
ation with mTORC1 inhibition. By cluster analysis, these
DEGs were generalized as biological process, cellular com-
ponent, and molecular function, including activation of
RNA polymerases and transcription factors; mTOR sig-
naling; and amino acid, lipid, carbohydrate, and single nu-
cleotide metabolism. Our bioinformatics results were
validated by qPCR analysis of 40 genes that were represen-
tative of the most relevant metabolic processes. We may
infer from the RNA-seq findings that the mTOR pathwaypromotes accumulation of excellent cashmere and meat
by regulating nutrients metabolism in cashmere goat.
These findings may be helpful to improve cashmere goat
breeding and its economical value or related industry.
mTORC1 has been argued to regulate the expression
of genes that are transcribed by RNA polymerase II and
that of transfer RNA (tRNA) and 5S rRNA through
modulation of RNA polymerase (Pol) III activity [27].
mTOR kinase is required for the control of RNA poly-
merase III-dependent transcription and might be linked
to the activities of all 3 RNA polymerases [30]. This
study provides evidence that the inhibition of mTOR
signaling affects the expression of eukaryotic RNA poly-
merase II subunit B1 and polymerase III subunits C31
and C37, indicating that mTOR signaling is involved in
the transcription of RNA polymerase II-related genes,
tRNA, snRNA and 5S rRNA.
In the past several years, many studies have claimed
that mTOR inhibition affects transcription by regulating
Fig. 8 CCI-779 treatment induces expression change in carbohydrate metabolism enzyme genes. AGA, RFT1, OGT (TTC5), ACYP1, and ACH1
(STARD10) were downregulated (green box) while CHST3, OGDH, PIGK, PGAM2, KHK, and Cyt b5R (LOC102173645) were upregulated (red box) in
CCI-779-treated GFbs (FDR ≦0.001 and fold-change ≧2). The black box indicates no significant change in expression
Fu et al. BMC Genomics  (2016) 17:879 Page 11 of 16the activation of specific transcription factors [27, 44].
Our transcriptomic analysis revealed 3 differentially
expressed transcription factors—TCF20, NRL, and
NFYB—the expression of which was related to
mTORC1. TCF20 (also called SPBP) is believed to be a
transcriptional coactivator of NRF2, which is a master
regulator of the response to oxidative stress and regu-
lates the basal and inducible expression of many antioxi-
dant pathway genes [45]. The depletion of TCF20
decreases the expression of the autophagy maker protein
LC3B [46] and autophagy machinery [47].
The neural retina leucine zipper transcription factor
NRL is essential for rod photoreceptor development
[48]. The activation of rod genes in cone-like precur-
sors depends on the induction of NRL [49]. E2F1 reg-
ulates cell proliferation and apoptosis by controlling
various target genes and combines with NFYB to
control the NFYB/E2F1 joint transcriptional program
[50, 51]. These transcription factors are primarily as-
sociated with cell autophagy, proliferation, and apop-
tosis, which are regulated by mTORC1 signaling. Our
data indicate that mTORC1 regulates several cellular
processes.
mTOR signaling is emerging as a significant regulator
of various metabolic processes through complex regula-
tory mechanisms [3]. It is believed that amino acids are
essential for mTORC1 activity [24], but the function ofmTOR in amino acid catabolism has not been reported.
Our data show that the inhibition of mTOR induces sig-
nificant changes in key enzymes in the metabolism of
several amino acids, indicating that mTORC1 governs
amino acid catabolism directly or indirectly.
Recent studies have shown that mTORC1 has a sig-
nificant function in regulating various aspects of lipid
metabolism in mammalian cells, including lipogenesis,
adipogenesis, lipolysis, and lipid oxidation [9]. In our
work, DEGs that encode important enzymes that are re-
lated to lipid metabolism were screened in CCI-779-
treated GFbs, indicating that mTOR signaling has a crit-
ical function in lipogenesis and lipolysis in goat fetal
fibroblasts.
mTOR has a significant function in energy homeostasis
[16], including lipid and glucose metabolism. Tight and
well-adapted balance of mTOR activity is required for
controlling energy homeostasis under physiological condi-
tions [52]. In addition, glucose consumption metabolically
restricts T cells, leading to dampened mTOR activity and
glycolytic capacity [19]. Our study has verified the pres-
ence of a series of DEGs in carbohydrate metabolism in
mTORC1-inhibited cells, demonstrating an important
function of mTOR signaling in energy homeostasis.
Moreover, we found that MO25, an upstream regula-
tor of AMP-activated protein kinase (AMPK), was
downregulated in CCI-779-treated cells. AMPK is a
Fig. 9 CCI-779 treatment induces expression change in single nucleotide metabolism enzyme genes. ndk (LOC102176263), GUCY1B3 and PDE8A
were downregulated (green box) and UCK1 and GUCY2F were upregulated (red box) in CCI-779-treated GFbs (FDR ≦0.001 and fold-change ≧2). The
black box indicates no significant change in expression
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status. The adaptor molecule MO25 recruits and acti-
vates LKB1 through the pseudokinase, STRAD [53]. En-
ergy stress induces a substantial increase in AMPK
activity through the LKB1/MO25/STARD complex [54].
Activated AMPK inhibits the stimulation of mTOR sig-
naling to regulate cell metabolism and energy homeosta-
sis, and the suppression and degradation of AMPK
effect the activation of mTOR signaling [55]. Notably,
the inhibition of mTOR signaling decreased the expres-
sion of MO25 in our study, suggesting that a new mech-
anism of mTORC1 regulation of energy homeostasis has
an important function in GFb cells.
Emerging evidence suggests that mTORC1 stimulates
the synthesis of single nucleotides, and mTORC1 posi-
tively regulates such anabolic processes as nucleotide
biosynthesis with sufficient nutrients [5]. Through the
SREBP transcription factors, mTORC1 upregulates pen-
tose phosphate pathway (PPP) genes and thus stimulates
the production of 5′-phosphoribosyl-1’-pyrophosphate
(PRPP), which acts as a ribose moiety for the synthesisof purine and pyrimidine nucleotides [6]. Further, two
recent studies demonstrated that mTORC1 stimulates
de novo pyrimidine biosynthesis through S6K1-mediated
phosphorylation and activation of CAD [7, 8]. Our study
identified several DEGs that are involved in single nu-
cleotide metabolism in CCI-779-treated cells. Pyrimi-
dines are high-energy molecules that drive specific
cellular reactions. UTP and CTP activate carbohydrates
for transfer to other molecules, and CTP is an energy
source for lipid synthesis. Our data indicate that
mTORC1 has a significant function in this metabolic
process by controlling the expression of key enzymes.
In this study, 40 significant DEGs with important
function related to mTOR signaling, RNA polymerase,
transcription factors and metabolism were selected for
qPCR analysis or western blot analysis, and the quantita-
tive results between the analysis methods were concord-
ant (Figs. 10 and 13). In the qPCR analysis, the
expression levels of the 40 DEGs showed a significant
difference in the fold changes (p < 0.05) (Fig. 11). More-
over, genes that encoded enzymes in amino acid, lipid,
Fig. 10 Forty differentially expressed genes (DEGs) in RNA-seq were validated by qPCR and show a high concordance. Comparison between
RNA-Seq and qPCR results. X-axis shows genes validated in this study, among which some genes have different gene name and symbol,
including GST (LOC102179473, LOC102189581, LOC102188913), mmsB (PSIP1), bdh (BDH2), CYP 1B1 (LOC102184252), PIK3C (PIK3CD), ATGL
(LIPG), FNTB (CHURC1), udk (UCK1), ndk (LOC102176263), Cyt b5R (LOC102173645), OGT (TTC5), ACH1 (STARD10), VEGF (LOC102177848),
RPB1 (ODF3L2); Y-axis shows log2ratio of expression of CCI-779 treatment versus control group. Positive value means upregulation, and
negative value means downregulation. The red column represents qPCR results, and the blue column represents the RNA-Seq results. The
results of the qPCR analysis for 40 genes with a significant difference and important function in amino acid, lipid, carbohydrate, and single nucleotide
metabolism, RNA polymerases, transcription factors and mTOR signaling show high concordance with RNA-Seq findings
Fig. 11 The differential expression of 40 DEGs in qPCR validation and the statistical analysis of the DEGs between control and CCI-779-treated
groups. X-axis shows genes validated in this study, among which some genes have different gene name and symbol, including GST (LOC102179473,
LOC102189581, LOC102188913), mmsB (PSIP1), bdh (BDH2), CYP 1B1 (LOC102184252), PIK3C (PIK3CD), ATGL (LIPG), FNTB (CHURC1), udk (UCK1), ndk
(LOC102176263), Cyt b5R (LOC102173645), OGT (TTC5), ACH1 (STARD10), VEGF (LOC102177848), RPB1 (ODF3L2); Y-axis shows log2ratio of expression
of CCI-779 treatment versus control group. The blue column represents the expression in control groups, and which value was defined as reference
value (1.0). The red column represents the differential expression fold change of CCI-779 treatment versus control group. The qPCR data are expressed
as the mean of triplicates, and error bars represent the standard deviation. Differences in means between control and CCI-779-treated
groups determined by Student’s T test. The differential expression between each DEG in control and CCI-779-treated groups are all
significantly different (p < 0.05)
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Fig. 12 Statistics of DEGs in different macromolecule metabolism. Genes that encoded enzymes in amino acid, lipid, carbohydrate, and single
nucleotide metabolism were differentially expressed in mTORC1-inhibited GFbs. Number of DEGs in lipid and carbohydrate metabolisms are more
than in amino acid and nucleotide metabolism
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differentially expressed in mTORC1-inhibited GFbs. The
number of DEGs in lipid and carbohydrate metabolism
is more than that in amino acid and nucleotide metabol-
ism. Thus, mTORC1 signaling might have disparate
functions in the metabolism of various macromolecules.
However, the new DEGs found in comparative transcrip-
tome profiling on Inner Mongolia Cashmere goat fetal
fibroblasts (GFbs) need to be verified and further
investigated.
Conclusions
We performed RNA-seq analysis to determine the ef-
fects of mTORC1 inhibition on the fetal fibroblast tran-
scriptome of Cashmere goat, an important breeding lineFig. 13 The expression of S6K1 and VEGF proteins in control and CCI-779-t
analysis, which the two genes expressed differently in RNA-seq. These two
779-treated groups and a consistence with the results of the transcriptiona
RNA-seq in the protein levels. a S6K1 and VEGF proteins were detected by
Analyzer 4.0 (Media Cybernetics, Inc., Rockville, MD, USA). β-actin was used
were carried out 3 times (Additional file 7: Figure S1) and the expression shfor the cashmere industry. mTORC1 inhibition induced
gene expression changes that were associated with cer-
tain physiological processes. Using a digital gene expres-
sion system, 365 DEGs were identified on mTORC1
inhibition, comprising 144 upregulated genes and 221
downregulated genes compared with the control group.
The DEGs were related to RNA polymerase subunits,
transcription factors, mTOR kinases, and amino acid,
lipid, carbohydrate, and single nucleotide metabolism,
indicating that they have significant function in GFbs.
The transcriptional expression of 40 DEGs that were
representative for the most relevant metabolic processes,
RNA polymerase, transcription factors and mTOR sig-
naling were analyzed by qPCR and western blot, and all
showed a high concordance with the RNA-Seq data.reated groups. S6K1 and VEGF proteins were detected by western blot
proteins showed a differential expression between control and CCI-
l levels. The data showed a preliminary significance of the findings of
western blot. b The resolved bands were quantified using Gel-Pro
as a loading control. The western blot detections of S6K1 and VEGF
owed a significant differences (p < 0.05)
Fu et al. BMC Genomics  (2016) 17:879 Page 15 of 16This report is the first study to indicate that mTOR sig-
naling is an important regulator of cell metabolism, and
has physiological significance in goat fetal fibroblasts
and provides valuable information on metabolism in
these cells.
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